Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 740947, 10 pages
http://dx.doi.org/10.1155/2014/740947
Research Article

Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments

1Department of Neurology, the First Hospital, Jilin University, Changchun 130021, China
2Department of Neurology, Wuxi People’s Hospital, Nanjing Medical University, Wuxi 214023, China
3Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden
4Department of Otorhinolaryngology, Head and Neck Surgery, the First Hospital, Jilin University, Changchun 130021, China
5Center for Infectious Medicine, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden

Received 18 December 2013; Revised 10 April 2014; Accepted 16 April 2014; Published 12 May 2014

Academic Editor: Fumio Tsuji

Copyright © 2014 Shujuan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. M. Hadden, D. R. Cornblath, R. A. C. Hughes et al., “Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome,” Annals of Neurology, vol. 44, no. 5, pp. 780–788, 1998. View at Google Scholar · View at Scopus
  2. T. W. Ho, B. Mishu, C. Y. Li et al., “Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies,” Brain, vol. 118, no. 3, pp. 597–605, 1995. View at Google Scholar · View at Scopus
  3. Z. Islam, B. C. Jacobs, A. Van Belkum et al., “Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh,” Neurology, vol. 74, no. 7, pp. 581–587, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Yuki and H. P. Hartung, “Guillain-Barré syndrome,” The New England Journal of Medicine, vol. 366, pp. 2294–2304, 2012. View at Google Scholar
  5. G. Borsellino, O. Koul, R. Placido et al., “Evidence for a role of γδ T cells in demyelinating diseases as determined by activation states and responses to lipid antigens,” Journal of Neuroimmunology, vol. 107, no. 2, pp. 124–129, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tatsumoto, M. Koga, M. Gilbert et al., “Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a,” Journal of Neuroimmunology, vol. 177, no. 1-2, pp. 201–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Deng, X. Yang, T. Jin et al., “The role of IL-12 and TNF-α in AIDP and AMAN,” European Journal of Neurology, vol. 15, no. 10, pp. 1100–1105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zhu, E. Mix, and H. Link, “Cytokine production and the pathogenesis of experimental autoimmune neuritis and Gulllain-Barre syndrome,” Journal of Neuroimmunology, vol. 84, no. 1, pp. 40–52, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. H. L. Zhang, S. Azimullah, X. Y. Zheng, X. K. Wang, N. Amir, E. P. Mensah-Brown et al., “IFN-gamma deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response,” Journal of Neuroimmunology, vol. 246, pp. 18–26, 2012. View at Google Scholar
  10. K. Hohnoki, A. Inoue, and C.-S. Koh, “Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage,” Journal of Neuroimmunology, vol. 87, no. 1-2, pp. 27–32, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. G. A. Putzu, D. Figarella-Branger, C. Bouvier-Labit, A. Liprandi, N. Bianco, and J. F. Pellissier, “Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre Syndrome,” Journal of the Neurological Sciences, vol. 174, no. 1, pp. 16–21, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Infante-Duarte, H. F. Horton, M. C. Byrne, and T. Kamradt, “Microbial lipopeptides induce the production of IL-17 in Th cells,” Journal of Immunology, vol. 165, no. 11, pp. 6107–6115, 2000. View at Google Scholar · View at Scopus
  13. S. Aggarwal, N. Ghilardi, M.-H. Xie, F. J. De Sauvage, and A. L. Gurney, “Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1910–1914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Miossec, T. Korn, and V. K. Kuchroo, “Interleukin-17 and type 17 helper T cells,” The New England Journal of Medicine, vol. 361, no. 9, pp. 888–898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Trifari, C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits, “Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells,” Nature Immunology, vol. 10, no. 8, pp. 864–871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Olsen, R. Rismo, G. Cui, R. Goll, I. Christiansen, and J. Florholmen, “TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation,” Cytokine, vol. 56, no. 3, pp. 633–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Schmechel, A. Konrad, J. Diegelmann et al., “Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status,” Inflammatory Bowel Diseases, vol. 14, no. 2, pp. 204–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Wolk, E. Witte, U. Hoffmann et al., “IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease,” Journal of Immunology, vol. 178, no. 9, pp. 5973–5981, 2007. View at Google Scholar · View at Scopus
  21. S. Kagami, H. L. Rizzo, J. J. Lee, Y. Koguchi, and A. Blauvelt, “Circulating Th17, Th22, and Th1 cells are increased in psoriasis,” Journal of Investigative Dermatology, vol. 130, no. 5, pp. 1373–1383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Brucklacher-Waldert, K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa, “Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis,” Brain, vol. 132, no. 12, pp. 3329–3341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. X.-L. Li, Y.-C. Dou, Y. Liu et al., “Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells,” Cellular Immunology, vol. 271, no. 2, pp. 455–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. K. Asbury and D. R. Cornblath, “Assessment of current diagnostic criteria for Guillain-Barre syndrome,” Annals of Neurology, vol. 27, pp. S21–S24, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. C. Hughes, J. M. Newsom-Davis, G. D. Perkin, and J. M. Pierce, “Controlled trial of prednisolone in acute polyneuropathy,” The Lancet, vol. 2, no. 8093, pp. 750–753, 1978. View at Google Scholar · View at Scopus
  26. W. I. McDonald, A. Compston, G. Edan et al., “Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis,” Annals of Neurology, vol. 50, no. 1, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. B. Torchinsky and J. M. Blander, “T helper 17 cells: discovery, function, and physiological trigger,” Cellular and Molecular Life Sciences, vol. 67, no. 9, pp. 1407–1421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Park, Z. Li, X. O. Yang et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Volpe, M. Touzot, N. Servant et al., “Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production,” Blood, vol. 114, no. 17, pp. 3610–3614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Zhang, J.-M. Li, X.-G. Liu et al., “Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis,” Journal of Clinical Immunology, vol. 31, no. 4, pp. 606–614, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Maimone, P. Annunziata, I. L. Simone, P. Livrea, and G. C. Guazzi, “Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy,” Journal of Neuroimmunology, vol. 47, no. 1, pp. 55–62, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Press, V. Ozenci, M. Kouwenhoven, and H. Link, “Non-TH1 cytokines are augmented systematically early in Guillain-Barré syndrome,” Neurology, vol. 58, no. 3, pp. 476–478, 2002. View at Google Scholar · View at Scopus
  35. A. R. Crow, D. Brinc, and A. H. Lazarus, “New insight into the mechanism of action of IVIg: the role of dendritic cells,” Journal of Thrombosis and Haemostasis, vol. 7, supplement 1, pp. 245–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-P. Hartung, “Advances in the understanding of the mechanism of action of IVIg,” Journal of Neurology, vol. 255, no. 3, pp. 3–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Andersson, L. Björk, U. Skansén-Saphir, and J. Andersson, “Pooled human IgG modulates cytokine production in lymphocytes and monocytes,” Immunological Reviews, vol. 139, no. 1, pp. 21–42, 1994. View at Google Scholar · View at Scopus
  38. I. N. Van Schaik, I. Lundkvist, M. Vermeulen, and A. Brand, “Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro,” Journal of Clinical Immunology, vol. 12, no. 5, pp. 325–334, 1992. View at Google Scholar · View at Scopus
  39. B. Hemmer, S. Nessler, D. Zhou, B. Kieseier, and H.-P. Hartung, “Immunopathogenesis and immunotherapy of multiple sclerosis,” Nature Clinical Practice Neurology, vol. 2, no. 4, pp. 201–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. S. Maddur, J. Vani, P. Hegde, S. Lacroix-Desmazes, S. V. Kaveri, and J. Bayry, “Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin,” Journal of Allergy and Clinical Immunology, vol. 127, no. 3, pp. 823.e7–830.e7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. S. Maddur, S. V. Kaveri, and J. Bayry, “Comparison of different IVIg preparations on IL-17 production by human Th17 cells,” Autoimmunity Reviews, vol. 10, no. 12, pp. 809–810, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Sugita, Y. Kawazoe, A. Imai, T. Kawaguchi, S. Horie, H. Keino et al., “Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease,” Journal of Immunology, vol. 190, pp. 5799–5808, 2013. View at Google Scholar